Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05446909 · ClinicalTrials.gov registry record · NA
Preventing Cognitive Decline
A NA study of Cognitive Decline, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05446909: Completed NA study of Cognitive Decline, sponsored by Arizona State University.
NCT05446909 is a NA study of Cognitive Decline that has completed, run by Arizona State University. The registered enrollment target is 40 participants, below the 1,149-participant average among 61 other Cognitive Decline trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05446909, a NA study of Cognitive Decline, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.
Primary Outcome
The percentage of trials correct on N-back working memory test; higher percentage of trials correct mean a better outcome.
Conditions Studied
Interventions
- BEHAVIORAL health education
- BEHAVIORAL IBMT mindfulness
Study Locations (1)
Arizona
- Arizona State University - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
What the finished NCT05446909 record still lists
NCT05446909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,149-participant average among 61 other Cognitive Decline trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which health education is the first listed.
NCT05446909 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05446909 about?
NCT05446909 is a clinical study titled "Preventing Cognitive Decline". The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.
What is the current status of trial NCT05446909?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-02-01. Estimated completion is 2023-02-28.
What conditions does trial NCT05446909 study?
This clinical trial studies the following conditions: Cognitive Decline.
What interventions are being tested in trial NCT05446909?
The interventions under investigation include: health education (BEHAVIORAL), IBMT mindfulness (BEHAVIORAL).
Who is sponsoring clinical trial NCT05446909?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05446909 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05446909's enrollment target sits among peer trials
40 54th of 61 higher than 8 of 61 other Cognitive Decline trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Decline trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
MindWalk Intervention for Older South Asian Caregivers of People With Cognitive Disabilities (CD)
RECRUITING · NA
-
Preventing Cognitive Decline by Reducing BP Target Trial
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Exercise Adherence and Cognitive Decline: Phase 2
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI